Latest Breaking News On - Med systems - Page 4 : vimarsana.com

Repro Med (KRMD): Top Detractor for Roubaix Capital in Q4'20

Repro Med (KRMD): Top Detractor for Roubaix Capital in Q4’20 Roubaix Capital LLC, an investment management firm, published its ‘Roubaix Fund Composite’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 26.63% was recorded by the fund for the Q4 of 2020, outperforming its HFRI Equity Hedge benchmark that delivered a 14.50% return but below its Russell 2000 index that had a 31.37% return. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. Roubaix Capital, in their Q4 2020 Investor Letter, said that Repro Med Systems, Inc. (NASDAQ: KRMD) was the largest detractor for their portfolio in the fourth quarter of 2020. Repro Med Systems, Inc. is a medical device designer and manufacturing company that currently has a $192 million market cap. For the past 3 months, KRMD delivered a 9.25% return and settled at $4.37 per share at the closing of February 12th.

Mid-Morning Market Update: Markets Edge Higher; Verizon Tops Q4 Views

Mid-Afternoon Market Update: Dow Rises 40 Points; Repro Med Systems Shares Plunge

Mid-Day Market Update: Crude Oil Down 0.5%; Vir Biotechnology Shares Spike Higher

(ALNA), (ATOS) - 12 Health Care Stocks Moving In Monday's After-Market Session